Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUCID trial of liberal versus conventional glucose control in ICU patients with type 2 diabetes
ACTRN12616001135404Phase 2Terminated
- Sponsor
- Royal Adelaide Hospital
- Start
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of human insulin in type 2 diabetes mellitus (T2DM) and critical illness (2 arms), sponsored by Royal Adelaide Hospital. Primary endpoint: Incident hypoglycaemia. Started May 2017; status: terminated.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)critical illness
Beyond the preview
Go deeper on ACTRN12616001135404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001135404.